Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rep. Burton gets subcommittee chair

Executive Summary

Former House Government Reform Committee Chair Dan Burton (R-Ind.) named to oversee newly created Subcommittee on Wellness & Human Rights. Subcommittee will address issues concerning public health policy, human rights and family health - providing Burton with a platform to continue his investigation of vaccine safety (1"The Pink Sheet" Dec. 16, 2002, p. 18)...

You may also be interested in...



House Vaccine Compensation Bill Could Open Door To Compromise With Frist

Vaccine Injury Compensation Program reform legislation that includes a compromise on liability provisions is possible, Rep. Dan Burton (R-Ind.) said

Lilly Says Thimerosal Provision Is Clarification Of Existing Law, Not Change

Thimerosal liability protection included in the Homeland Security legislation is a clarification of existing law rather than a change, Lilly says

Setback For Athenex, Hanmi As CRL Requests New Trial

Hanmi partner Athenex has had a US complete response letter for its oral paclitaxel plus encequidar product for the treatment of metastatic breast cancer, amid concerns of safety risks associated with an increase in neutropenia-related sequelae. While the decision marks another setback for Hanmi in the US, Athenex is aiming to resolve the issues.

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel